Categories AlphaGraphs, Earnings, Health Care

Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today.

Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally.

Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60.

For the full year of 2024, Pfizer expects revenues of $59.5-62.5 billion. Adjusted EPS is expected to be $2.45-2.65.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Key metrics from Biogen’s (BIIB) Q4 2024 earnings results

Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion.   Net income attributable to Biogen Inc. was $266.8 million,

Important takeaways from Coca-Cola’s (KO) Q4 2024 earnings

The Coca-Cola Company (NYSE: KO) has wrapped up fiscal 2024 on an upbeat note, reporting stronger-than-expected results for the final quarter of the year. Encouraged by the growth in sales

Walt Disney (DIS): A look at the performance of the streaming business in 1Q25

Shares of The Walt Disney Company (NYSE: DIS) dropped 1% on Tuesday. The stock has gained 6% over the past three months. The company delivered top and bottom line growth

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close